magnolol has been researched along with Cancer of Skin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chilampalli, C; Dwivedi, C; Fahmy, H; Hildreth, MB; Kaushik, RS; Young, A; Zeman, D; Zhang, X | 1 |
| Chilampalli, C; Dwivedi, C; Fahmy, H; Guillermo, R; Hildreth, MB; Kaushik, RS; Young, A; Zeman, D; Zhang, X | 1 |
2 other study(ies) available for magnolol and Cancer of Skin
| Article | Year |
|---|---|
Chemopreventive effects of combination of honokiol and magnolol with α-santalol on skin cancer developments.
Topics: Animals; Anticarcinogenic Agents; Apoptosis; Biphenyl Compounds; Cell Proliferation; Drug Therapy, Combination; Female; Lignans; Mice; Neoplasms, Radiation-Induced; Polycyclic Sesquiterpenes; Sesquiterpenes; Skin Neoplasms; Ultraviolet Rays | 2013 |
Effects of magnolol on UVB-induced skin cancer development in mice and its possible mechanism of action.
Topics: Animals; Anticarcinogenic Agents; Apoptosis; Biphenyl Compounds; Blotting, Western; Carcinoma, Squamous Cell; Caspases; Cell Cycle Checkpoints; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cyclin-Dependent Kinases; Cyclins; Flow Cytometry; Intracellular Signaling Peptides and Proteins; Lignans; Mice; Neoplasms, Radiation-Induced; Phosphorylation; Skin Neoplasms; STAT3 Transcription Factor; Ultraviolet Rays | 2011 |